Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.
Peired AJ, Antonelli G, Angelotti ML, Allinovi M, Guzzi F, Sisti A, Semeraro R, Conte C, Mazzinghi B, Nardi S, Melica ME, De Chiara L, Lazzeri E, Lasagni L, Lottini T, Landini S, Giglio S, Mari A, Di Maida F, Antonelli A, Porpiglia F, Schiavina R, Ficarra V, Facchiano D, Gacci M, Serni S, Carini M, Netto GJ, Roperto RM, Magi A, Christiansen CF, Rotondi M, Liapis H, Anders HJ, Minervini A, Raspollini MR, Romagnani P. Peired AJ, et al. Among authors: lasagni l. Sci Transl Med. 2020 Mar 25;12(536):eaaw6003. doi: 10.1126/scitranslmed.aaw6003. Sci Transl Med. 2020. PMID: 32213630
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC).
Boni C, Savoldi L, Bisagni G, Ceci G, Crinò L, De Lisi V, Di Costanzo F, Lasagni L, Manenti AL, Moretti G, Rondini E, Sassi M, Zadro A. Boni C, et al. Among authors: lasagni l. Eur J Cancer. 1998 Nov;34(12):1974-6. doi: 10.1016/s0959-8049(98)00231-7. Eur J Cancer. 1998. PMID: 10023325 Clinical Trial.
Localization of endothelin-converting enzyme-1 in human kidney.
Pupilli C, Romagnani P, Lasagni L, Bellini F, Misciglia N, Emoto N, Yanagisawa M, Rizzo M, Mannelli M, Serio M. Pupilli C, et al. Among authors: lasagni l. Am J Physiol. 1997 Nov;273(5):F749-56. doi: 10.1152/ajprenal.1997.273.5.F749. Am J Physiol. 1997. PMID: 9374838
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M. Romagnani P, et al. Among authors: lasagni l. Am J Pathol. 2002 Jul;161(1):195-206. doi: 10.1016/S0002-9440(10)64171-5. Am J Pathol. 2002. PMID: 12107104 Free PMC article.
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P. Lasagni L, et al. J Exp Med. 2003 Jun 2;197(11):1537-49. doi: 10.1084/jem.20021897. J Exp Med. 2003. PMID: 12782716 Free PMC article.
Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines.
Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S. Cosmi L, et al. Among authors: lasagni l. Blood. 2004 Apr 15;103(8):3117-21. doi: 10.1182/blood-2003-09-3302. Epub 2003 Dec 24. Blood. 2004. PMID: 15070693 Free article.
88 results